chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initial report was received 17 June 2010 via a lay press publication dated 16 June 2010 which involved six patients in the same geographical area who had been diagnosed with pertussis after they had received five previous DTaP vaccinations (lot number not reported). The information contained in the lay press publication had been retrieved on 16 June 2010. This case represents one of the six reported patients. The other patients are captured in case numbers 2010-03433, 2010-03434, 2010-03435, 2010-03436 and 2010-03437. A 14-year-old patient (gender not reported) had received five prior doses of DTaP vaccine (manufacturers, lot numbers, routes, sites and dates of administration not reported) and an unspecified amount of time after receiving their fifth dose DTaP vaccination, the patient was diagnosed with pertussis. This patient was one out of six local children who had been diagnosed with pertussis. Outcome was not reported. No additional information was provided at the time of the report. Documents held by sender: News Release.
Numbness tingling weakness on left side fatigue almost feels like my leg wants to give out like something is related muscle or nerve related. Fluctuating blood pressure.
SARS-CoV-2 RdRp Resp Ql NAA+probe~COVID-19 rapid diagnostic test (nucleic acid amplification test NAAT) performed on 7/11/21 and came back positive. Test performed at a Walgreens not in New York, but most likely in Wisconsin. Case investigation interview with patient has not been performed at the time this note was written.
Initial and follow up information has been received from a physician's assistant concerning a 17 year old white female student with no previous medical history, who on 25-JUL-2007 was vaccinated with the first dose, on 26-SEP-2007 with the second dose and on 30-JAN-2008 with the third dose of GARDASIL (lot number: 659055/1522U).  Concomitant therapy included minocycline HC1 (DENTOMYCIN (minocycline hydrochloride)) and drospirenone (+) ethinyl estradiol (YAZ).  On 30-JAN-2008 after the 3rd and final vaccination the patient at the check out window had a syncopal episode.  She regained awareness in a matter of < 1 minute.  She did have an episode of vomiting after regaining awareness.  Subsequently the patient recovered.  The patient did not experience any reaction or adverse effect after the 1st and 2nd dose of vaccines.  Additional information has been requested. 07/08/08 Initial and follow up information has been received from a physician's assistant concerning a 17 year old female student with no previous medical history, who on 25-JUL-2007 was vaccinated with the first dose, on 26-SEP-2007 with the second dose and on 10-JAN-2008 with the third dose of GARDASIL (lot number: 659055/1522U). Concomitant therapy included DENTOMYCIN and YAZ. On 30-JAN-2008 after the 3rd and final vaccination the patient at the check out window had a syncopal episode. She regained awareness in a matter of < 1 minute. She did have an episode of vomiting after regaining awareness. Subsequently the patient recovered. The patient did not experience any reaction or adverse effect after the 1st and 2nd dose of vaccines. Additional information has been requested.
Pt presented to pharmacy with a large raised area that was red and warm to touch - pt complained of no pain - 2 days after injection - pt was to take BENADRYL - pt went to dr and received a steroid ointment.
Redness left arm; red areas hot to touch; Fever; headache; had pain during the injection that went down her left arm; swollen lymph notes; This case was reported by a nurse via call center representative and described the occurrence of fever in a 67-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 13th August 2019, the patient received Shingrix (intramuscular). On 13th August 2019, several hours after receiving Shingrix, the patient experienced fever, headache, pain in arm and enlargement of lymph nodes. On 15th August 2019, the patient experienced erythema of extremities and skin warm. On an unknown date, the outcome of the fever and erythema of extremities were unknown and the outcome of the headache was resolved with sequelae and the outcome of the pain in arm, enlargement of lymph nodes and skin warm were recovering/resolving.   It was unknown if the reporter considered the fever, headache, pain in arm, enlargement of lymph nodes, erythema of extremities and skin warm to be related to Shingrix.  Additional information received were as follows: On 13th August 2019, the patient received Shingrix to her left deltoid at 2pm. The patient stated that she developed a fever just hours after the shot. The patient developed a headache the same night she had the injection but that it went away. The patient stated that she had pain during the injection that went down her left arm. Till the time of reporting patient was continuing to have pain to her left arm and swelling to her left axillary lymph nodes. On the day of reporting the patient noticed two red areas that are painful, red and hot to the touch. The patient stated that the first area was 4 inches down from the injection site and that it was about the size of a dime. The second area was about 5 inches down from the injection site and was ovular and about 3.5 inches wide or size of a half dollar. The patient called her pharmacist who told her to follow up with her healthcare professional but that she was on her way to another country. The patient consented to follow up.
The night of vaccination I noticed my nose was plugged up and I had breathing trouble, I had to concentrate on taking slow deep breaths, then I started having small partial seizure activity. I had a mild headache and yesterday I had a bad headache and continuous partial seizures but never a grand mall, I had to lay down and work my way through it by medicating myself.. I am not aware of aa complete grand mall seizure and I had chills and stayed in bed all day. I live alone and didn't know if it was bad or not.
located many comments and a group of women who have all had the exact break out; This case was reported by a consumer and described the occurrence of psoriasis in an unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced psoriasis. On an unknown date, the outcome of the psoriasis was unknown.   It was unknown if the reporter considered the psoriasis to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not applicable for this report. While perusing the internet, the reporter located many comments and a group of women who have all had the exact break out psoriasis. This case has been linked to US2020AMR038938, reported by the same reporter.
60 seconds after receiving MMR states she felt a reaction coming, BENADRYL 25mg PO was given & voice began disappearing & stated hard to breathe. EPIPEN given & 25mg IM BENADRYL per Dr order & O2 placed & in 15 minutes a second episode began with voice changing & 2nd Epi given & transferred to ER via ambulance.
4" X 3" redness and induration, warm to touch, very painful to touch, and mild pain with movement
CRITICAL CONDITION; This spontaneous report received from a consumer concerned an adult female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient was in critical condition and hospitalized (date unspecified). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of critical condition was not reported. This report was serious (Hospitalization Caused / Prolonged). This case, from the same reporter is linked to 20210530468.; Sender's Comments: V0:20210536620-COVID-19 VACCINE AD26.COV2.S-Critical condition. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
child looked small for age so asked additional questions before vaccinating individual.  When the child was asked DOB they said 8/9/2009, when asked what grade going into...answered 6th.  Asked DOB again in conversation, again was told 8/9/09, without hesitation.  Went ahead with vaccination.  While they were waiting their 15 minutes, I asked mom to verify spelling of childs name and if they've had vaccinations in state before.  Mother responded that he had.  I asked who the pediatrician was, she gave me Dr -who is a local pediatrician.  I called the office, they had no record of patient with 8/9/09 DOB, I asked them to search name without DOB, they found the name with a 8/26/2010 DOB.  I looked that patient/DOB up in database and address, mothers maiden name all matched the vaccine consent form.  I went to the counter and asked mom to come back up.  I asked her his DOB again and she again said 8/9/09, I asked her to tell me the truth since I knew this to not be correct.  She then said she must have made a mistake.  I told her that she falsified medical records and I would notify the  Dr and report this as well.  She asked if we were done here and said she was leaving.  Vaccination card was not provided since information on it was not accurate.  The vaccine was entered into database under the correct profile of Pt DOB 8/26/10
pt recv vax & devel hives several hr p/vax;pt treated w/atarax;hives resolved;
No further adverse events; patient was administered PROQUAD via IM route; This spontaneous report was received from a registered nurse refers to a 5-year-old patient of unknown gender. Information regarding the patient's pertinent medical history, concurrent condition, drug reactions/allergies and concomitant medications was not provided.     On 18-MAR-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) albumin status: rHA (lot # U028181, expiration date was reported as 08-MAR-2023, dose and strength were not provided) intramuscularly for prophylaxis (incorrect route of product administration). No additional information available. No further adverse events/no product quality complaint.
Shaking chills and muscle aches starting about 12 hours after vaccination followed by fever, nausea and dizziness about 20 hours after vaccine.  Symptoms gradually improved over next 12 - 16 hours.  All symptoms  except fatigue resolved by 48 hours .  Fatigue gradually resolved over next two days.
No reaction - form completed due to wrong age group.  Date of vaccination applies, no reaction just incorrect vaccine given.
This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (tested positive for COVID) in a 66-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     Specific product reported: No, product was inferred.    On 16-Feb-2021, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to 1 dosage form.
This spontaneous case was reported by a consumer and describes the occurrence of SWOLLEN TONGUE (Swelling under her tongue) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 18-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced SWOLLEN TONGUE (Swelling under her tongue). At the time of the report, SWOLLEN TONGUE (Swelling under her tongue) outcome was unknown. No concomitant medications reported. No treatment information provided.
This spontaneous report was received from a healthcare worker and refers to multiple patients of unknown demographics. The patients' concurrent conditions, medical history and concomitant medications were not reported. On an unknown date, the patients' were vaccinated with improperly stored doses of ROTATEQ lot # L039228 with expiration date of 27-JUN-2017 (dose, strength, and route unknown). The vaccine was exposed to temperature of 71.2 Fahrenheit (F) for 7 hours and 31.8 F for 106 hours. Data logger was involved. It was unknown if there was any previous temperature excursion. No adverse effects were reported. This is one of the several reports from the same reporter. Additional information has been requested.
Contacted by father "after hours" who left description of adverse reaction on 4/25/06. Home visit made by public health nurse (vaccine administered) on 4/26/06 AM. Patient outside playing. Mother showed PHN right arm. Elbow to shoulder area swollen 1 1/2 X 2 X normal size. Area hard, warm, red and painful with 2-3 inch area /// injection site blistered. Mother had placed warm compresses. Physician notified. On 4/26/06, physician presented Zithromax. Physician agreed to make home visit.
reports, "I got my second covid vaccine Lot 031L20A vaccine to my left arm around 1540 the day before, 2/10 and I woke up fine".   reports, "around 9 ish, I felt cold but was told it is always cold on this floor and while standing in patient room, 10 minutes later, I felt nausea and dizzy, then realized I was falling to the floor and hit the floor but used both hands to lessen the fall and then hit the left side of my nose".   denies any headache, nose bleeding, hitting head or LOC.    reports,  "someone from the unit took me down to the ED by wheelchair".   reports, " I was fully aware I was falling".   denies any problems with lighting, monitors, headache, visual or gait disturbance".
NODE ON LEFT SIDE SOME REDNESS AROUND THE IT. PLACE LOCATED WHERE DTAP WAS ADMINISTERED. PARENT REPORTS PAIN FOR PATIENT WHEN WALKING.
My symptoms began with visual impairment, then a migraine. I then had memory loss and was unable to remember the name of my street or my roommates. I could not think or speak clearly and had trouble reading.
My pain intensity is higher  .  3 weeks after vaccinated.  Got stung 5 times on ankles area by yellow jackets.  Pain was awful , very very bad. Never felt that type of pain from any bee stings  ?- other everyday pain was elevated.  On 7?13?21 I had a total right Knee replacement. And I notice afterwards that pain was  very intense, hardly any  pain I.v. Worked in recovery. And the days following that pain meds didn?t do much at all.    I never experienced this happening in past surgeries ,accidents. Med. problems. Etc..    also nerve  Sensations in legs
Patient received three vaccines on 8/19/20. She also received the first dose of Shingrix, but it was in the right arm. Patient developed a small rash on the left deltoid where the Boostrix and Prevnar were administered. Patient has just experienced a rash and no other complications
the patient had no symptoms or adverse events following administration; nurse who reports administration of vaccines following temperature excursion.; This spontaneous report has been received from a nurse referring to a patient of an unknown age and gender.  The patient's medical history, concurrent conditions, concomitant medications, and previous drug allergies or reactions were not provided.  On 29-JUN-2022, the patient was vaccinated with  a improperly stored hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) at a dose of 0.5 milliliter once, lot number U034200, expiration date: 21-OCT-2023, prophylaxis (strength, vaccination scheme, and route of administration were not provided) following a temperature excursion of minus 0.8 degrees Celsius (C) for 1 hour 10 minutes (product storage error), there was stated that no previous temperature excursion occurred. The patient had no symptoms or adverse events following administration of the vaccine.  This is one of several cases from the same reporter.
had an allergic reaction; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): 2023NVX-US-000001243 (Novavax).  A female patient received bnt162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HYPERSENSITIVITY (non-serious), outcome "unknown", described as "had an allergic reaction".  Clinical information: On 29Sep2023, it was reported that a patient started treatment on an unreported date with Pfizer BioNTech COVID-19 vaccine dose 1 for an unreported indication. It was reported the patient had an allergic reaction on an unreported date, so she could not take Pfizer or Moderna. The individual had J&J for dose 2 of her primary series, then 1 as a booster (dose 3) on unreported dates.   The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.
3 days after taking the Tdap shot, I started having flashes of light around my left eye, floaters, and blurred vision in the same eye, still do not have full vision in that eye
administration of improperly stored PROQUAD; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. Information regarding the patient's  medical history, concurrent conditions and concomitant medications was not provided. On 29-SEP-2020, the patient was vaccinated with improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) lot # T015598 with expiration date of 02-NOV-2021, for prophylaxis.  The administered vaccine experimented temperature of excursión of 20.5 degrees Fahrenheit for 1 hour 54 minutes 0 seconds; previous temperature excursion? 6 degrees Fahrenheit  to 14 degrees Fahrenheit  (12.3F) for 23 hours 0 minutes  0seconds. Digital data logger was involved.
Information has been received from a medical assistant referring to multiple patients of unknown age and gender. The patients' medical history, concurrent condition and concomitant medication were unknown. On multiple unspecified dates, the patients were administered improperly stored RECOMBIVAX HB (dose and route unknown, lot # L033343, expiration date: 13-SEP-2017). The vaccines were exposed to temperature excursions in 3 different refrigerators, but not exposed to multiple excursions. The three refrigerators are described as "A: temperature: max 48 Fahrenheit degree for 15 hours, B: temperature: max 49.3 Fahrenheit degree for 15 hours, and C temperature max 51.4 Fahrenheit degree for 15 hours". There were no previous excursions. There was no data logger. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
After 10 days, still have fatigue and facial and scalp tingling (comes and goes).  Pain in injection site reoccured overnight (night 10) and injection site is sore to the touch after 10 days.  New feeling of some leg weakness today. First seven days included fatigue, chills, facial/scalp tingling, headache.
On first try, wheal was not formed from injection. Had to repeat dose in Right Forearm. Another nurse did the repeat dose, RN.
Patient experienced itching on right arm she took diphenhydramine about 15 minutes after the vaccination.. EMS was called vitals HR 88  BP 183/100 sitting BP 182/78 standing. Patient waited in garage 10 minutes to see if symptoms resolve. Released against medical advise.
Observed High Blood Pressure (145/93) and high pulse rate (92) - Doctor prescribed no medication. Still observing high blood pressure since a month.
Developed diffuse urticaria 2 days after 2nd injection of vaccine; required treatment with steroids/antihistamines, gradually cleared over 5 days
Dizziness; Weakness; sore in the injection site; redness in the injection site; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), ASTHENIA (Weakness), VACCINATION SITE PAIN (sore in the injection site) and VACCINATION SITE ERYTHEMA (redness in the injection site) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025620-4) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced DIZZINESS (Dizziness), ASTHENIA (Weakness), VACCINATION SITE PAIN (sore in the injection site) and VACCINATION SITE ERYTHEMA (redness in the injection site). At the time of the report, DIZZINESS (Dizziness), ASTHENIA (Weakness), VACCINATION SITE PAIN (sore in the injection site) and VACCINATION SITE ERYTHEMA (redness in the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the event, a causal relationship cannot be excluded.
Pt received the vaccination at approximately 4:25pm on 6/21/2021.  Pharmacist went over potential side effects before administration.  Pharmacist administered the vaccine, filled out his paperwork, and then stood up.  Pt stood up.  Pharmacist started to ask him to wait in the pharmacy waiting area for 15 minutes so we could make sure that he did not have a reaction.  Before the pharmacist could finish, the Patient started to sway.  He leaned against the wall, started to bend over, hit his head on the wall, and passed out.  The pharmacist called for help from the other staff.  Pt's legs were lifted up so that his feet were resting on the chair.  He had hit the bridge of his nose against the wall/side of door.  His nose was swelling up, turning black and blue, and was starting to bleed.  After about 15 seconds, the patient came around.  He was able to answer questions coherently.  He stated that he did  not need an ambulance.  Pharmacist retrieved a couple of ice packs for him and put his coat under his head.  Patient remained lying down for approximately 30 minutes before he stood up.  When he stood up, he did not sway and seemed stable.  Pt declined the pharmacy staff to contact someone to drive him home.
On June 18, 2022 I was feeling a little bit under the weather and on June 19, 2022, I woke up with symptoms. Very bad headache, from my sinus to the top of my head, nasal congestion, and sore throat. The symptoms changed through the days. I have lost my taste and smell. My nose is very dry as well. I tested positive for COVID-19 on June 19th, 21st, and 23rd and they were all positive. I contacted Dr., and told him that I tested positive. He told me to up my dosage of zinc, vitamin C and D3.
Patient's left arm red, hot, swollen 24 hours after shot.  Flu like symptoms for 2 days.  Erythema today 15 x 17 cm in diameter.
Patient's family states that pt complaint of Rt arm discomfort after the shot. Arm hurt, then arm hurt all the way up to shoulder and down and now client has a limp. Client's family instructed to take him to seek medical care. (Client does not have a doctor).
Slight Headache (ibuprofen) Fatigue (sleep) Vomiting  Nausea (crackers, peppermint tea) Abdominal pain after eating and woke up with it 1/20/2021 (still happening) Diaherra (stopped on 1/19/2021)